Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Weber

Showing results (191-200 of 221) with videos related to

Pageof 23
Sort By:
Transplantation and Cellular Therapy|September 2, 2021
Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host DiseaseMakda Getachew Zewde, George Morales, Isha Gandhi, et al.
Blood Immunology & Cellular Therapy|May 15, 2026
Systemic steroid treatment of grade I acute GVHD increases steroid-refractory GVHD and NRMYu Akahoshi, Nikolaos Katsivelos, Ioannis E Louloudis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2022
Conditioning Regimens are Associated with Distinct Patterns of Microbiota Injury in Allogeneic Hematopoietic Cell TransplantationRoni Shouval, Nicholas R Waters, Antonio L C Gomes, et al.
Leukemia|May 4, 2018
Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia-results of the AMLSG 11-08 trialPeter Paschka, Richard F Schlenk, Daniela Weber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2017
Intestinal Microbiota and Relapse After Hematopoietic-Cell TransplantationJonathan U Peled, Sean M Devlin, Anna Staffas, et al.
Antioxidants (Basel, Switzerland)|August 28, 2025
Causal Inference Approaches Reveal Associations Between LDL Oxidation, NO Metabolism, Telomere Length and DNA Integrity Within the MARK-AGE StudyAndrei Valeanu, Denisa Margina, María Moreno-Villanueva, et al.
Nature|October 24, 2024
Rifaximin prophylaxis causes resistance to the last-resort antibiotic daptomycinAdrianna M Turner, Lucy Li, Ian R Monk, et al.
Leukemia|January 23, 2024
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohortsJacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, et al.
Blood Advances|April 20, 2022
Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratificationAaron Etra, Stephanie Gergoudis, George Morales, et al.
JCI Insight|February 15, 2017
An early-biomarker algorithm predicts lethal graft-versus-host disease and survivalMatthew J Hartwell, Umut Özbek, Ernst Holler, et al.
Pageof 23

Showing results (191-200 of 221) with videos related to

Sort By:
Pageof 23
Transplantation and Cellular Therapy|September 2, 2021
Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host DiseaseMakda Getachew Zewde, George Morales, Isha Gandhi, et al.
Blood Immunology & Cellular Therapy|May 15, 2026
Systemic steroid treatment of grade I acute GVHD increases steroid-refractory GVHD and NRMYu Akahoshi, Nikolaos Katsivelos, Ioannis E Louloudis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2022
Conditioning Regimens are Associated with Distinct Patterns of Microbiota Injury in Allogeneic Hematopoietic Cell TransplantationRoni Shouval, Nicholas R Waters, Antonio L C Gomes, et al.
Leukemia|May 4, 2018
Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia-results of the AMLSG 11-08 trialPeter Paschka, Richard F Schlenk, Daniela Weber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2017
Intestinal Microbiota and Relapse After Hematopoietic-Cell TransplantationJonathan U Peled, Sean M Devlin, Anna Staffas, et al.
Antioxidants (Basel, Switzerland)|August 28, 2025
Causal Inference Approaches Reveal Associations Between LDL Oxidation, NO Metabolism, Telomere Length and DNA Integrity Within the MARK-AGE StudyAndrei Valeanu, Denisa Margina, María Moreno-Villanueva, et al.
Nature|October 24, 2024
Rifaximin prophylaxis causes resistance to the last-resort antibiotic daptomycinAdrianna M Turner, Lucy Li, Ian R Monk, et al.
Leukemia|January 23, 2024
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohortsJacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, et al.
Blood Advances|April 20, 2022
Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratificationAaron Etra, Stephanie Gergoudis, George Morales, et al.
JCI Insight|February 15, 2017
An early-biomarker algorithm predicts lethal graft-versus-host disease and survivalMatthew J Hartwell, Umut Özbek, Ernst Holler, et al.
Pageof 23